Cardiac steroidogenesis in the normal and failing heart

被引:109
作者
Young, MJ
Clyne, CD
Cole, TJ
Funder, JW
机构
[1] Baker Med Res Inst, Prahran, Vic 3181, Australia
[2] Prince Henrys Inst Med Res, Clayton, Vic 3168, Australia
关键词
D O I
10.1210/jc.86.11.5121
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The present study explores the possibility of local de novo aldosterone production in normal and failing hearts (human and mouse) and the regulation of such putative cardiac steroidogenesis. Total RNA was isolated from human tissue from failing hearts taken at the time of cardiac transplantation, from normal hearts obtained at autopsy, and from normal and pressure-overloaded mouse hearts. Vascular smooth muscle cells from human artery and vein were also analyzed. RNA was reverse transcribed and probed with specific primers for side-chain cleavage enzyme (CYP11A), 3 beta -hydroxysteroid dehydrogenase, aldosterone synthase (CYP11B2), 11 beta -hydroxylase (CYP11B1), steroidogenic factor-1, and steroid acute regulatory protein. CYP11A, 3 beta -hydroxysteroid dehydrogenase-2, and steroid acute regulatory protein were expressed at modest levels in all tissues examined in both mouse and human. In failing human heart, CYP11B1 and CYP11B2 were detected in some samples, in contrast with normal hearts, which expressed neither; in the mouse heart steroidogenic factor-1 was detected, but neither CYP11B1 nor CYP11B2 was found. Steroidogenic factor-1 was detected in no human heart sample tested after 40 cycles of PCR. Although the expression of some steroidogenic genes can be detected in the heart, the likelihood of physiologically relevant levels of aldosterone production by the normal heart is very low. The exact cellular location of steroid synthesis in the failing human heart remains to be established.
引用
收藏
页码:5121 / 5126
页数:6
相关论文
共 20 条
[1]  
BRILLA CG, 1992, J LAB CLIN MED, V120, P257
[2]   Targeted disruption of the mouse gene encoding steroidogenic acute regulatory protein provides insights into congenital lipoid adrenal hyperplasia [J].
Caron, KM ;
Soo, SC ;
Wetsel, WC ;
Stocco, DM ;
Clark, BJ ;
Parker, KL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (21) :11540-11545
[3]   EXTRAADRENAL FORMATION OF A MINERALOCORTICOSTEROIDS - DEOXYCORTICOSTERONE AND DEOXYCORTICOSTERONE SULFATE BIOSYNTHESIS AND METABOLISM [J].
CASEY, ML ;
MACDONALD, PC .
ENDOCRINE REVIEWS, 1982, 3 (04) :396-403
[4]   TARGETED DISRUPTION OF THE GLUCOCORTICOID RECEPTOR GENE BLOCKS ADRENERGIC CHROMAFFIN CELL-DEVELOPMENT AND SEVERELY RETARDS LUNG MATURATION [J].
COLE, TJ ;
BLENDY, JA ;
MONAGHAN, AP ;
KRIEGLSTEIN, K ;
SCHMID, W ;
AGUZZI, A ;
FANTUZZI, G ;
HUMMLER, E ;
UNSICKER, K ;
SCHUTZ, G .
GENES & DEVELOPMENT, 1995, 9 (13) :1608-1621
[5]   CENTRAL MINERALOCORTICOID RECEPTOR ANTAGONISM BLOCKS HYPERTENSION IN DAHL S/JR RATS [J].
GOMEZSANCHEZ, EP ;
FORT, C ;
THWAITES, D .
AMERICAN JOURNAL OF PHYSIOLOGY, 1992, 262 (01) :E96-E99
[6]  
HATAKEYAMA H, 1994, J BIOL CHEM, V269, P24316
[7]   Steroidogenic enzyme gene expression in the human heart [J].
Kayes-Wandover, KM ;
White, PC .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (07) :2519-2525
[8]  
Mizuno Y, 2001, CIRCULATION, V103, P72
[9]   Steroidogenic factor 1: A key determinant of endocrine development and function [J].
Parker, KL ;
Schimmer, BP .
ENDOCRINE REVIEWS, 1997, 18 (03) :361-377
[10]   The effect of spironolactone on morbidity and mortality in patients with severe heart failure [J].
Pitt, B ;
Zannad, F ;
Remme, WJ ;
Cody, R ;
Castaigne, A ;
Perez, A ;
Palensky, J ;
Wittes, J .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (10) :709-717